Related references
Note: Only part of the references are listed.Suppression of inflammation and acquired immunity by IL-37
Giulio Cavalli et al.
IMMUNOLOGICAL REVIEWS (2018)
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease
Luisa Chiapparini et al.
JOURNAL OF NEUROLOGY (2018)
The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease
Greta Pacini et al.
ONCOIMMUNOLOGY (2018)
Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance
Giulio Cavalli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Advances in potential targeted therapies for Erdheim-Chester disease
Giulio Cavalli et al.
EXPERT OPINION ON ORPHAN DRUGS (2017)
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study
Serena Colafrancesco et al.
FRONTIERS IN PHARMACOLOGY (2017)
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
Giulio Cavalli et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tocilizumab in patients with multisystem Erdheim-Chester disease
Alvise Berti et al.
ONCOIMMUNOLOGY (2017)
Recurrent pericarditis: new and emerging therapeutic options
Massimo Imazio et al.
NATURE REVIEWS CARDIOLOGY (2016)
Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease
Eli L. Diamond et al.
BLOOD (2016)
Treating Life-Threatening Myocarditis by Blocking Interleukin-1
Giulio Cavalli et al.
CRITICAL CARE MEDICINE (2016)
Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence The AIRTRIP Randomized Clinical Trial
Antonio Brucato et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Erdheim-Chester Disease With Multiorgan Involvement, Following Polycythemia Vera A Case Report
Alessandra Iurlo et al.
MEDICINE (2016)
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
Giulio Cavalli et al.
RHEUMATOLOGY (2016)
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease
Elisabetta Ferrero et al.
ONCOIMMUNOLOGY (2016)
Rapid progression to cardiac tamponade in Erdheim-Chester disease despite treatment with interferon alpha
Afif Nakhleh et al.
MODERN RHEUMATOLOGY (2016)
Treating Pulmonary Silicosis by Blocking Interleukin 1
Giulio Cavalli et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)
Yehuda Adler et al.
EUROPEAN HEART JOURNAL (2015)
An enlightening scan
Lorenzo Canziani et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
Erdheim-Chester disease
Corrado Campochiaro et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies
Giulio Cavalli et al.
RHEUMATOLOGY (2015)
Efficacy and safety of biological agents in adult-onset Still's disease
G. Cavalli et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2015)
BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease
Maria Giulia Cangi et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases
George Lazaros et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
Eli L. Diamond et al.
BLOOD (2014)
Formation of the inflammasome in acute myocarditis
Stefano Toldo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein
Audrey Courcoul et al.
JOINT BONE SPINE (2014)
TNF-alpha in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab
Elisabetta Ferrero et al.
RHEUMATOLOGY (2014)
Oncogene-induced senescence as a new mechanism of disease: the paradigm of Erdheim - Cnester disease
Giulio Cavalli et al.
FRONTIERS IN IMMUNOLOGY (2014)
Diagnosing Erdheim-Chester disease
Giulio Cavalli et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases
Giulio Cavalli et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
Julien Haroche et al.
BLOOD (2013)
The heart on fire: inflammasome and cardiomyopathy
Antonio Abbate
EXPERIMENTAL PHYSIOLOGY (2013)
Erdheim-Chester disease with cardiac involvement successfully treated with anakinra
Ammar M. Killu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Recurrent pericarditis: Autoimmune or autoinflammatory?
Silvia Maestroni et al.
AUTOIMMUNITY REVIEWS (2012)
Tumor Necrosis Factor α As a Master Regulator of Inflammation in Erdheim-Chester Disease: Rationale for the Treatment of Patients With Infliximab
Lorenzo Dagna et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Charles A. Dinarello et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients
Laurent Arnaud et al.
BLOOD (2011)
Autoinflammatory Disease Reloaded: A Clinical Perspective
Daniel L. Kastner et al.
CELL (2010)
Share Paper
